Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis

Multiple Sclerosis Journal

Volumn 18, Issue 11, 2012, Pages 1577-1584

  Filli, Lukas ^a   Hofstetter, Louis ^a   Kuster, Pascal ^a   Traud, Stefan ^a   Mueller Lenke, Nicole ^a   Naegelin, Yvonne ^a   Kappos, Ludwig ^a   Gass, Achim ^a   Sprenger, Till ^a   Nichols, Thomas E ^b   Vrenken, Hugo ^c   Barkhof, Frederik ^c   Polman, Chris ^c   Radue, Ernst Wilhelm ^a   Borgwardt, Stefan J ^a   Bendfeldt, Kerstin ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

lesion probability maps; MRI; Multiple sclerosis; relapsing remitting; secondary progressive; T1 hypointense lesions; T2 hyperintense lesions; white matter

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; BRAIN; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; DISABILITY; DISEASE COURSE; EUROPE; FEMALE; HUMAN; LEUKOENCEPHALOPATHY; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; TIME;

ADULT; ANALYSIS OF VARIANCE; BRAIN; CHI-SQUARE DISTRIBUTION; DISABILITY EVALUATION; DISEASE PROGRESSION; EUROPE; FEMALE; HUMANS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 84862284430     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512442756     Document Type: Article

References (37)

1. Tremlett H, Yinshan Z, Devonshire V. Natural history of secondary-progressive multiple sclerosis. Mult Scler. 2008 ; 14: 314-324 (Pubitemid 351676426)
2. Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 2008 ; 131: 808-817 (Pubitemid 351294716)
3. Barkhof F, Calabresi PA, Miller DH, et al. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol. 2009 ; 5: 256-266
4. Rovira A, Leon A. MR in the diagnosis and monitoring of multiple sclerosis: an overview. Eur J Radiol. 2008 ; 67: 409-414
5. Zivadinov R, Stosic M, Cox JL, et al. The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome. J Neurol. 2008 ; 255: 61-74 (Pubitemid 351341874)
6. Minneboo A, Uitdehaag BM, Ader HJ, et al. Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients. Neurology. 2005 ; 65: 56-61 (Pubitemid 40967776)
7. Ceccarelli A, Rocca MA, Pagani E, et al. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage. 2008 ; 42: 315-322
8. Lee MA, Smith S, Palace J, et al. Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?. Brain. 1999 ; 122: 1261-1270 (Pubitemid 29324847)
9. Kesselring J. The pathogenesis of multiple sclerosis. Schweiz Med Wochenschr. 1990 ; 120: 1083-1090
10. Van Walderveen MA, Lycklama ANGJ, Ader HJ, et al. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol. 2001 ; 58: 76-81 (Pubitemid 32053210)
11. Drake MA, Carra A, Allegri RF, et al. Differential patterns of memory performance in relapsing, remitting and secondary progressive multiple sclerosis. Neurol India. 2006 ; 54: 370-376 (Pubitemid 44870687)
12. Gaudino EA, Chiaravalloti ND, DeLuca J, et al. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis. Neuropsychiatry Neuropsychol Behav Neurol. 2001 ; 14: 32-44 (Pubitemid 32179135)
13. Huijbregts SC, Kalkers NF, de Sonneville LM, de Groot V, Reuling IE, Polman CH. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology. 2004 ; 63: 335-339 (Pubitemid 38971136)
14. Kincses Z, Ropele S, Jenkinson M, et al. Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis. Mult Scler. 2011 ; 17: 681-689
15. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol. 2002 ; 15: 239-245 (Pubitemid 34596884)
16. Bendfeldt K, Blumhagen JO, Egger H, et al. Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis. Hum Brain Map. 2010 ; 31: 1542-1555
17. Sepulcre J, Goni J, Masdeu JC, et al. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway. Arch Neurol. 2009 ; 66: 173-179
18. Vellinga MM, Geurts JJ, Rostrup E, et al. Clinical correlations of brain lesion distribution in multiple sclerosis. J Magn Reson Imaging. 2009 ; 29: 768-773
19. Bendfeldt K, Kuster P, Traud S, et al. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study. Neuroimage. 2009 ; 45: 60-67
20. Enzinger C, Smith S, Fazekas F, et al. Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study. J Neurol. 2006 ; 253: 1064-1070 (Pubitemid 44441133)
21. Klein JC, Behrens TE, Robson MD, et al. Connectivity-based parcellation of human cortex using diffusion MRI: Establishing reproducibility, validity and observer independence in BA 44/45 and SMA/pre-SMA. Neuroimage. 2007 ; 34: 204-211 (Pubitemid 44765247)
22. Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp. 2002 ; 15: 1-25 (Pubitemid 34020610)
23. Dalton C, Bodini B, Samson R, et al. Brain lesion location and clinical status status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler. 2012 ; 18: 322-328
24. Chard DT, Griffin CM, Parker GJM, et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain. 2002 ; 125: 327-337 (Pubitemid 34127435)
25. Owen DR, Piccini P, Matthews PM. Towards molecular imaging of multiple sclerosis. Mult Scler. 2011 ; 17: 262-272
26. Zivadinov R, Stosic M, Cox J, et al. The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome. J Neur. 2008 ; 255: 61-74 (Pubitemid 351341874)
27. Bendfeldt K, Egger H, Nichols TE, et al. Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis-a longitudinal MRI study. Brain Res. 2010 ; 1325: 174-182
28. Furby J, Hayton T, Altmann D, et al. A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis. Jf Neurol. 2010 ; 257: 1508-1516
29. Charil A, Zijdenbos AP, Taylor J, et al. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage. 2003 ; 19: 532-544 (Pubitemid 36918200)
30. DeCarli C, Fletcher E, Ramey V, et al. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke. 2005 ; 36: 50-55 (Pubitemid 40054174)
31. Di Perri C, Battaglini M, Stromillo ML, et al. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Arch Neurol. 2008 ; 65: 236-243 (Pubitemid 351240787)
32. Ghassemi R, Antel SB, Narayanan S, et al. Lesion distribution in children with clinically isolated syndromes. Ann Neurol. 2008 ; 63: 401-405 (Pubitemid 351499870)
33. Bendfeldt K, Hofstetter L, Kuster P, et al. Longitudinal gray matter changes in multiple sclerosis-Differential scanner and overall disease-related effects. Hum Brain Map. 2011 ;:
34. Tekok-Kilic A, Benedict RH, Weinstock-Guttman B, et al. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage. 2007 ; 36: 1294-1300 (Pubitemid 47007715)
35. Smieskova R, Fusar-Poli P, Allen P, et al. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?-a systematic review. Curr Pharm Des. 2009 ; 15: 2535-2549
36. Wu G, Wang Q, Jia H, et al. Feature-based groupwise registration by hierarchical anatomical correspondence detection. Hum Brain Map. 2012 ; 33: 253-271
37. Sepulcre J, Liu H, Talukdar T, et al. The organization of local and distant functional connectivity in the human brain. PLoS Comput Biol. 2010 ; 6: e1000808